Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Buchegger

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 22, 2018
The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An <sup>18</sup>F-MISO PET-MRI StudyIsmini C Mainta, Thomas Zilli, Jean-Christophe Tille, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2014
N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imagingEleni Gourni, Rosalba Mansi, Mazen Jamous, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 29, 2009
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective studyDamien C Weber, Nathalie Casanova, Thomas Zilli, et al.
Biomaterials|November 3, 2009
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermiaPol-Edern Le Renard, Olivier Jordan, Antonin Faes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
(11)C-acetate PET in the early evaluation of prostate cancer recurrenceSusanne Albrecht, Franz Buchegger, Dmitri Soloviev, et al.
Clinical Nuclear Medicine|September 8, 2012
Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better toleranceFranz Buchegger, John O Prior, Gilles Allenbach, et al.
International Journal of Cancer|April 1, 2004
Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenograftsFranz Buchegger, Florence Adamer, Andreas Oliver Schaffland, et al.
Clinical & Developmental Immunology|December 28, 2013
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patientsFranz Buchegger, Steven M Larson, Jean-Pierre Mach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2005
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kineticsCristian Antonescu, Angelika Bischof Delaloye, Marek Kosinski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2012
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotideAriane Boubaker, John O Prior, Jean-Pierre Willi, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Radiation Oncology, Biology, Physics|April 22, 2018
The Effect of Neoadjuvant Androgen Deprivation Therapy on Tumor Hypoxia in High-Grade Prostate Cancer: An <sup>18</sup>F-MISO PET-MRI StudyIsmini C Mainta, Thomas Zilli, Jean-Christophe Tille, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 23, 2014
N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imagingEleni Gourni, Rosalba Mansi, Mazen Jamous, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 29, 2009
Recurrence pattern after [(18)F]fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma: a prospective studyDamien C Weber, Nathalie Casanova, Thomas Zilli, et al.
Biomaterials|November 3, 2009
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermiaPol-Edern Le Renard, Olivier Jordan, Antonin Faes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
(11)C-acetate PET in the early evaluation of prostate cancer recurrenceSusanne Albrecht, Franz Buchegger, Dmitri Soloviev, et al.
Clinical Nuclear Medicine|September 8, 2012
Longer intervals between hematopoietic stem cell transplantation and subsequent 90Y-ibritumomab radioimmunotherapy may correlate with better toleranceFranz Buchegger, John O Prior, Gilles Allenbach, et al.
International Journal of Cancer|April 1, 2004
Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenograftsFranz Buchegger, Florence Adamer, Andreas Oliver Schaffland, et al.
Clinical & Developmental Immunology|December 28, 2013
Radioimmunotherapy combined with maintenance anti-CD20 antibody may trigger long-term protective T cell immunity in follicular lymphoma patientsFranz Buchegger, Steven M Larson, Jean-Pierre Mach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 13, 2005
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kineticsCristian Antonescu, Angelika Bischof Delaloye, Marek Kosinski, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2012
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotideAriane Boubaker, John O Prior, Jean-Pierre Willi, et al.
Pageof 5